Boeing (BA) appointed CFO James Bell as President and CEO on an interim basis, replacing Harry Stonecipher who was asked to resign due to his personal relationship with a female Boeing executive who did not report directly to him.
Sony Corp. (SNE) gains after CEO Nobuyuki Idei resigned and handed reins to Howard Stringer, head of U.S. operations, according to the Wall Street Journal.
Qualcomm Inc. (QCOM) cuts $1.35 billion to $1.45 billion second-quarter revenue forecast to $1.35 billion to $1.40 billion on GAAP basis, but raises 24 cents to 26 cents earnings per share forecast to 25 cents to 27 cents (both including a penny loss attributable to the QSI segment). S&P reiterates strong buy.
Insiders at Martha Stewart Living (MSO) sold nearly 5 million Martha Stewart shares compared with total purchases of 500,000, according to Barron's.
GE (GE) is to sell up to 82 million shares of Genworth Financial (GNW) through a secondary public offering and a sale to Citigroup Global Markets, an affiliate of which intends to conduct public offering of security exchangeable for Genworth shares.
Cisco Systems (CSCO) rises after having slimmed to a market p-e. The tech giant may start attracting new crowd: value investors, according to Barron's.
Capital One Financial (COF) agreed to acquire New Orleans-based lender Hibernia Corp. (HIB) in a cash and stock deal valued at $5.3 billion. Terms of the agreement give cash or Capital One stock valued at $15.35, plus the value at closing of 0.2261 Capital One Share, giving a total per-share value of about $33 per Hibernia share.
Medarex Inc. (MEDX) and Bristol-Myers (BMY) announced results of an early clinical study with investigational fully human anti-CTLA-4 antibody, MDX-010, in which eight of 36 patients with metastatic melanoma experienced objective clinical responses.
Marvel Enterprises (MVL) posted 27 cents, vs. 12 cents fourth-quarter earnings per share on a 17% sales rise. The company sees 25 cents to 29 cents first-quarter earnings per share, abd $1.07 to $1.12 2005 earnings per share.
Royal Caribbean (RCL) signs a letter of intent with Aker Finnyards in Finland to add a third ship to its Freedom class of vessels now being built for Royal Caribbean. The company estimates the cost of the third ship at $230,000 per berth, at current exchange rates.
Boston Scientific (BSX) says 9-month results from the Taxus V clinical trial, confirming safety and efficacy of Taxus Express2 paclitaxel-eluting coronary stent system for treatment of coronary artery disease, met its primary and secondary endpoints.
Banc of America upgrades AnnTaylor (ANN) to buy from neutral.
Celgene Corp. (CELG) says an external Independent Data Monitoring Committee analyses of both Phase III Special Protocol Assessment multiple myeloma trials of Revlimid exceeded pre-specified p
Prudential upgrades Talbots Inc. (TLB) to overweight from underweight.
Vascular Solutions (VASC) receives approval from the Japanese Ministry of Health and Labor & Welfare for the Pronto extraction catheter, which is designed for mechanical aspiration removal of acute thrombus from the arterial system.
Piper Jaffray reportedly downgrades Research In Motion (RIMM) to market perform from outperform.
Walter Industries (WLT) ups 2005 earnings per share guidance by 30 cents to $2.50 to $3.10. The company cites better-than-expected pricing on Jim Walter Resources' metallurgical coal contracts.
Maxcor Financial Group (MAXF) says it is holding preliminary discussions with a potential acquirer.